Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg - capsule, modified release - excipient ingredients: magnesium stearate; povidone; hydrogenated vegetable oil; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate

United States - English - NLM (National Library of Medicine)

janssen pharmaceuticals, inc. - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine 8 mg - razadyne er is indicated for the treatment of mild to moderate dementia of the alzheimer's type. razadyne er is contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of razadyne er or galantamine tablets in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically (see data). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. data animal data in rats, administration of galantamine (oral doses of 2, 8, or 16 mg/kg/da

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; hydrogenated vegetable oil; povidone; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 30.768 mg - capsule, modified release - excipient ingredients: hydrogenated vegetable oil; povidone; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; polyvinyl acetate; titanium dioxide; allura red ac; potable water; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: povidone; magnesium stearate; hydrogenated vegetable oil; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Malta - English - Medicines Authority

syri limited - galantamine - oral solution - galantamine 4 mg/ml - psychoanaleptics

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the alzheimer's type. galantamine hydrobromide extended-release capsules are contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of galantamine hydrobromide extended-release capsules in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically (see data). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unkn

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - galantamine hydrobromide (unii: mj4ptd2vvw) (galantamine - unii:0d3q044kca) - galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the alzheimer's type. galantamine hydrobromide extended-release capsules are contraindicated in patients with known hypersensitivity to galantamine hydrobromide or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of galantamine hydrobromide extended-release capsules in pregnant women. in studies conducted in animals, administration of galantamine during pregnancy resulted in developmental toxicity (increased incidence of morphological abnormalities and decreased growth in offspring) at doses similar to or greater than those used clinically (see data). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unkn

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - galantamine - tablets - 4 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - galantamine - tablets - 8 milligram